1Yamaguchi H,Ishimura T,Nishyama S,et al. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol,1979,44:401-412.
3Eriksson MJ,Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J AM Coll Cardiol,2000,39:638-645.
4Abinader EG, Sharif D, Shefer A, et al. Novel insights into the natural history of apical hypertrophic cardiomyopathy during long-term follow-up. Isr Med Assoc J, 2002, 4: 166-169.
5Otto CM, Pearhnan AS. Textbook of clinical echocardiography, cardiomyopathies, liypertensive and pulmonary heart disease. Ontario: Saunders Company, 1995 : 171-172.
6van der Lee C,ten Cate FJ,Geleijnse ML,et al. Percutaneousversus surgical treatment for patients with hypertrophic obstructivecardiomyopathy and enlarged anterior mitral valve leaflets.Circulation,2005 ,112:482488.
7Firoozi S,Elliott PM,Sharma S,et al. Septal myotomy-myectomyand transcoronary septal alcohol ablation in hypertrophicobstructive cardiomyopathy. A comparison of clinical,haemodynamic and exercise outcomes. Eur Heart J,2002,23 :16174624.
8Nagueh SF,Ommen SR,Lakkis NM,et al. Comparison ofethanol septal reduction therapy with surgical myectomy for thetreatment of hypertrophic obstructive cardiomyopathy. J Am CollCardiol ,2001,38:1701-1706.
9Qin JX,Shiota T,Lever HM,et al. Outcome of patients withhypertrophic obstructive cardiomyopathy after percutaneoustransluminal septal myocardial ablation and septal myectomysurgery. J Am Coll Cardiol,2001,38:1994-2000.
10Sigwart U. Non-surgical myocardial reduction for hypertrophicobstructive cardiomyopathy. Lancet,1995,346:211-214.
